Cargando…
Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care
Autores principales: | Asif, Sana, Frithiof, Robert, Lipcsey, Miklos, Kristensen, Bjarne, Alving, Kjell, Hultström, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645408/ https://www.ncbi.nlm.nih.gov/pubmed/33158455 http://dx.doi.org/10.1186/s13054-020-03362-y |
Ejemplares similares
-
Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study
por: Asif, Sana, et al.
Publicado: (2023) -
The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients
por: Järhult, Josef D., et al.
Publicado: (2021) -
Infectious SARS-CoV-2 is rarely present in the nasopharynx samples collected from Swedish hospitalized critically ill COVID-19 patients
por: Ling, Jiaxin, et al.
Publicado: (2022) -
Blood type A associates with critical COVID-19 and death in a Swedish cohort
por: Hultström, Michael, et al.
Publicado: (2020) -
The swedish covid‐19 intensive care cohort: Risk factors of ICU admission and ICU mortality
por: Ahlström, Björn, et al.
Publicado: (2021)